Literature DB >> 27108542

International trends in spice use: Prevalence, motivation for use, relationship to other substances, and perception of use and safety for synthetic cannabinoids.

George Loeffler1, Eileen Delaney2, Michael Hann3.   

Abstract

Synthetic cannabinoids (SC), commonly known as Spice, are a class of compounds that share affinity for the cannabinoid receptors. Recreational use of SCs has grown in recent years. A literature search was conducted of national and international organizations as well as peer-reviewed publications describing SC use in non-clinical populations. Our primary goal was summarizing SC use prevalence within the general population from representative surveys. Our secondary goals included describing SC use frequency, motivation for use, the relationship between SC use and use of other substances, and perception of SC use including beliefs about safety and use by peers. Nationally and regionally representative surveys describe lifetime prevalence of SC use in the general population as between 0.2% and 4%. Longitudinal data, though limited, shows decline in SC use with peak use occurring in the late teens and early twenties. Users tend to be males. The majority of SC users report using only a small number of times and use tends to not be sustained. The most common motive for SC use is curiosity. SC users generally report a history of extensive use of other substances. Perception of SC use by others tends to be significantly greater than actual SC use. Published by Elsevier Inc.

Entities:  

Keywords:  Epidemiology; Motivation; Prevalence; Spice; Synthetic cannabinoids; Synthetic marijuana

Mesh:

Substances:

Year:  2016        PMID: 27108542     DOI: 10.1016/j.brainresbull.2016.04.013

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  11 in total

Review 1.  Cannabinoid exposure during pregnancy and its impact on immune function.

Authors:  Catherine Dong; Jingwen Chen; Amy Harrington; K Yaragudri Vinod; Muralidhar L Hegde; Venkatesh L Hegde
Journal:  Cell Mol Life Sci       Date:  2018-10-29       Impact factor: 9.261

2.  Adolescent cannabinoid exposure modulates the vulnerability to cocaine-induced conditioned place preference and DNMT3a expression in the prefrontal cortex in Swiss mice.

Authors:  P H Gobira; A L Roncalho; N R Silva; G P Silote; A J Sales; S R Joca
Journal:  Psychopharmacology (Berl)       Date:  2021-07-30       Impact factor: 4.530

Review 3.  Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.

Authors:  Zurina Hassan; Oliver G Bosch; Darshan Singh; Suresh Narayanan; B Vicknasingam Kasinather; Erich Seifritz; Johannes Kornhuber; Boris B Quednow; Christian P Müller
Journal:  Front Psychiatry       Date:  2017-08-18       Impact factor: 4.157

4.  Personality Traits and Psychotic Proneness Among Chronic Synthetic Cannabinoid Users.

Authors:  Koby Cohen; Shiri Rosenzweig; Paola Rosca; Albert Pinhasov; Abraham Weizman; Aviv Weinstein
Journal:  Front Psychiatry       Date:  2020-05-15       Impact factor: 4.157

5.  Synthetic cannabinoid use in psychiatric patients and relationship to hospitalisation: A retrospective electronic case register study.

Authors:  Melissa Hobbs; Rashmi Patel; Paul D Morrison; Nicola Kalk; James M Stone
Journal:  J Psychopharmacol       Date:  2020-02-28       Impact factor: 4.153

6.  Behavioral Effects of Developmental Exposure to JWH-018 in Wild-Type and Disrupted in Schizophrenia 1 (disc1) Mutant Zebrafish.

Authors:  Judit García-González; Bruno de Quadros; William Havelange; Alistair J Brock; Caroline H Brennan
Journal:  Biomolecules       Date:  2021-02-19

7.  Analytical findings in a non-fatal intoxication with the synthetic cannabinoid 5F-ADB (5F-MDMB-PINACA): a case report.

Authors:  Franziska Gaunitz; Hilke Andresen-Streichert
Journal:  Int J Legal Med       Date:  2021-12-18       Impact factor: 2.791

8.  Psychiatric symptoms and synthetic cannabinoid use: Information for clinicians.

Authors:  Gary Sweet; Sara Kim; Samuel Martin; Nicole B Washington; Nancy Brahm
Journal:  Ment Health Clin       Date:  2018-03-26

Review 9.  Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective.

Authors:  Koby Cohen; Aviv M Weinstein
Journal:  Front Public Health       Date:  2018-06-07

Review 10.  Epigenetic Effects of Drugs of Abuse.

Authors:  Thomas Heinbockel; Antonei B Csoka
Journal:  Int J Environ Res Public Health       Date:  2018-09-25       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.